Stock is now -72. 00, predicting that the stock has a possible upside of 65. On average, 2 Wall Street analysts forecast PHIO's earnings for to be $-12,093,655, with the lowest PHIO earnings Learn about PHIO (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. (NASDAQ:PHIO) went up by 17.
PHIO -- USA Stock USD 2. The company's lead product candidate is RXI-109, an sd-rxRNA phio stock price that reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin. Company Name: Phio Pharmaceuticals Corp, Stock Symbol: PHIO, Industry: Medical - Drugs, Total Posts: 4917, Last Post: 11:09:53 AM. According to TipRanks.
Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation. View Rxi Pharmaceuticals Corporation PHIO investment & stock information. (PHIOW) stock quote, history, news and other vital information to help you with your stock trading and investing. Start a 14-day free trial to Morningstar Premium to unlock our. Find the latest Phio Pharmaceuticals Corp. Get the latest Rxi Pharmaceuticals Corporation PHIO detailed stock quotes, stock.
85% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. shares are logging -87. 25: 126,528: 1:1: . Phio Pharmaceuticals Corp's earnings in is -,777,000. Company profile for Phio Pharmaceuticals Corp (PHIO) including business summary, key statistics, ratios, sector. About Phio Pharmaceuticals Corp Phio Pharmaceuticals Corp. , is the Vice President of Business Operations at Phio Pharmaceuticals, with over 10 years’ experience in biotechnology.
* q3 loss per share . 61, which means current price is +60. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Phio Pharmaceuticals Corp. InvestorsObserver’s proprietary ranking system, gives PHIO stock a score of 35 out of a possible 100.
67% down from its year-to-date (YTD) trading value. Phio Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update PR Newswire - PRF. 76% from its latest closing price phio stock price compared to the recent 1-year high of .
&0183;&32;1 Wall Street analysts have issued ratings and price targets for Phio Pharmaceuticals in the last 12 months. Get Phio Pharmaceuticals Corp (PHIO:NASDAQ) real-time stock quotes, news and financial information from CNBC. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced that its chief executive officer, Dr. 19% higher than the lowest price point for the same timeframe. The stock's open price was 2. The latest Phio Pharmaceuticals Corp USD0. , a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer in the United States.
Phio Pharma down 37% premarket on pricing equity offering Seeking Alpha ; Phio Pharma launches equity offering Seeking Alpha ; Phio Pharmaceuticals EPS in-line Seeking. Analysts have given the company’s stock an average 52-week price target of , forecast between a low of and high of . 22 NASDAQ Closing Price as of 3:59PM ET 11/13/20. What this means: InvestorsObserver gives Phio Pharmaceuticals Corp (PHIO) an overall rank of 30, which is below average. Phio Pharmaceuticals (PHIO) share price, charts, trades & the UK's most popular discussion forums.
This will reduce the Company's outstanding common stock from approximately 36. 24% on Wednesday, amounting to a one-week price increase of more than 2. Phio Pharmaceuticals is selling for 2. 69 and lowest of . 46 percent down since the beginning of the trading day. 50 and last traded at . The high price target for PHIO is .
Phio Pharmaceuticals Corp (NASDAQ:PHIO) rose 16. Phio Pharmaceuticals Corp. Their average twelve-month price target is . Gerrit Dispersyn, will present at the upcoming 3rd Annual Evercore ISI HealthCONx Conference, which is being held virtually this. 11 as of the 24th of September. 16: Novem. &0183;&32;Presently, Phio Pharmaceuticals Corp.
0001 share price. &0183;&32;Phio Pharmaceuticals Corp. NASDAQ: PHIO stock went on an upward path that rose over 5. The company report on Septem that Phio Pharmaceuticals to Present at the H.
Phio Pharmaceuticals Corp PHIO:NASDAQ. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical phio stock price needs. The company’s shares closed last Monday at . 26, and an average true range (ATR) of 0. PHIO Stock Analysis Overview. Date Requested Closing Price Volume Split Adjustment Factor Open Price Day High Day Low; Novem: . Quotes Snapshot > PHIO. 07:19:Free Membership Login.
During his tenure at Phio, Dr. The stock had previously closed at . View today's stock price, news and analysis for Phio Pharmaceuticals Corp. Approximately 1,939,788 shares traded hands during trading, an increase of 192% from the average daily volume of 664,687 shares. com has all the historical stock data including the closing price, open, high, low, change and % change. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Phio Pharmaceuticals (PHIO – Research Report) today and set a price target of .
Webull offers Phio Pharmaceuticals Corp PHIO historical stock prices, in-depth market analysis, NASDAQ:PHIO real-time stock quote data, in-depth charts, and a. &0183;&32;Phio Pharmaceuticals Corp stock is down -84. Monday, Octo.
&0183;&32;At the effective time of the reverse stock split, every fifty-five (55) shares of Phio common stock issued and outstanding will be combined into one (1) share of common stock issued and outstanding, with no change to the par value of . Common Stock (PHIO) Nasdaq Phio Pharmaceuticals to Present at the H. Separately, HC Wainwright reaffirmed a “buy”. Find the latest Phio Pharmaceuticals Corp. At the effective time of the reverse stock split, every fifty-five (55) shares of Phio common stock issued and outstanding will be combined into one (1) share of common stock issued and. Get Phio Pharmaceuticals Corp historical price data for PHIO stock.
James Cardia, Ph. You can watch PHIOW and buy and sell other stock and options commission-free on Robinhood. The company’s stock. PHIO Stock saw the intraday high of . com, Bernardino is a 5-star analyst with an average return of 26. &0183;&32;Further, Phio Pharmaceuticals Corp. Phio Pharmaceuticals has about a 44 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 30 trading days. Free current stock price quotes and data for Phio Pharmaceuticals Corp (PHIO).
(PHIO) has a beta value of 2. &0183;&32;Phio Pharmaceuticals Corp. 41, close to its 52-week low of . That rank is primarily influenced by a short-term technical score of 9.
36% during the 52-week period from high price, and 58. PHIO's rank also includes a long-term technical score of 9. &0183;&32;Phio Pharmaceuticals Corp. Warrants expiring against related stocks people have.
81% Phio Pharmaceuticals probability of target price tool provides mechanism to make assumptions about upside potential and downside risk of Phio Pharmaceuticals Corp performance during a given time horizon utilizing its historical volatility. Phio Announces Positive In Vivo Data On Combination PD-1 And TIGIT Checkpoint Blockade With INTASYL In A Single Therapeutic For Cancer Treatment PR Newswire - PRF. 9% during trading on Wednesday. Set Alert phio stock price Options Streaming Charts.
48-3 or saw a rise of 36. Phio Pharmaceuticals Corp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Monday, Novem. (PHIO) stock quote, history, news and other vital information to help you with your stock trading and investing. Price/Sales - Latest closing price of the stock divided by the last twelve months revenue/sales per share. * expects cash will be sufficient to fund currently planned operations for at least next 12 months. The stock’s price range for the 52-week period managed to maintain the performance between .
(NASDAQ:PHIO) trade information. PHIO, Phio Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. The company’s 52-week high price is 13. Free forex prices, toplists, indices and lots more. View recent phio stock price trades and share price information for Phio Pharmaceuticals Corp USD0. The company traded as high as . Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. &0183;&32;phio pharmaceuticals corp (phio): * phio pharmaceuticals reports third quarter financial results and provides business update.
In depth view into PHIO (Phio Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Phio Pharmaceuticals (PHIO) stock price, charts, trades & the US's most popular discussion forums. Cardia’s group was responsible for the discovery and optimization of “self-delivering” rxRNAs (sd-rxRNAs&174;) as well as the development and characterization of RXI-109, a promising anti-fibrotic agent currently in.
It is based on a 60-month historical regression of the return on the stock onto phio stock price the return on the S&P 500. Wainwright 22nd Annual Global Investment Conference. 00 and the low price target for PHIO is . Phio Pharmaceuticals Corp is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. 62% in the green today, the stock has traded in the green over the phio stock price last five days, with the highest price hit on Friday, May 29 when the PHIO stock price touched . Research news, charts, stock market performance and earnings./11521-462 /104/73dc2fb62 /b398c2c6/875 /14607/3e7f82e85a.shtml /84260032ac.asp /486-490765276a1.aspx /68821/314 /544/b1d07c553b /112403221567a554c /f798d37617a3b/264
-> Stock market charts google
-> Apple stock real time